Hereditary hemorrhagic telangiectasia type 1 and 2 mutations in Finland

References

• Kjeldsen AD, Vase P, Green A. Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. J Intern Med 1999; 245: 31–9
   PubMed Web of Science ®Google Scholar
• Begbie ME, Wallace GM, Shovlin CL. Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century. Postgrad Med J 2003; 79: 18–24
   PubMed Web of Science ®Google Scholar
• Abdalla SA, Letarte M. Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease. J Med Genet 2006; 43: 97–110
   PubMed Web of Science ®Google Scholar
• Illum P, Bjerring P. Hereditary hemorrhagic telangiectasia treated by laser surgery. Rhinology 1988; 26: 19–24
   PubMedGoogle Scholar
• Drettner B, Svensson C. Follow-up of patients with hereditary hemorrhagic telangiectasia in the nose, with special reference to septal dermoplasty. Rhinology 1983; 21: 251–5
   PubMedGoogle Scholar
• Fiorella ML, Ross D, Henderson KJ, White RI, Jr. Outcome of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia. Laryngoscope 2005; 115: 301–5
   PubMed Web of Science ®Google Scholar
• Weissman JL, Jungreis CA, Johnson JT. Therapeutic embolization for control of epistaxis in a patient with hereditary hemorrhagic telangiectasia. Am J Otolaryngol 1995; 16: 138–40
   PubMed Web of Science ®Google Scholar
• Abdalla SA, Gallione CJ, Barst RJ, Horn EM, Knowles JA, Marchuk DA, et al. Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia. Eur Respir J 2004; 23: 373–7
   PubMed Web of Science ®Google Scholar
• Prigoda NL, Savas S, Abdalla SA, Piovesan B, Rushlow D, Vandezande K, et al. Hereditary haemorrhagic telangiectasia: mutation detection, test sensitivity and novel mutations. J Med Genet 2006; 43: 722–8
   PubMed Web of Science ®Google Scholar
• Bossler AD, Richards J, George C, Godmilow L, Ganguly A. Novel mutations in ENG and ACVRL1 identified in a series of 200 individuals undergoing clinical genetic testing for hereditary hemorrhagic telangiectasia (HHT): correlation of genotype with phenotype. Hum Mutat 2006; 27: 667–75
   PubMed Web of Science ®Google Scholar
• Fernandez A, Sanz-Rodriguez F, Zarrabeitia R, Perez-Molino A, Morales C, Restrepo CM, et al. Mutation study of Spanish patients with hereditary hemorrhagic telangiectasia and expression analysis of Endoglin and ALK1. Hum Mutat 2006; 27: 295
   Google Scholar
• Lenato GM, Lastella P, Di Giacomo MC, Resta N, Suppressa P, Pasculli G, et al. DHPLC-based mutation analysis of ENG and ALK-1 genes in HHT Italian population. Hum Mutat 2006; 27: 213–14
   PubMed Web of Science ®Google Scholar
• Lesca G, Burnichon N, Raux G, Tosi M, Pinson S, Marion MJ, et al. Distribution of ENG and ACVRL1 (ALK1) mutations in French HHT patients. Hum Mutat 2006; 27: 598
   PubMedGoogle Scholar
• Gallione CJ, Repetto GM, Legius E, Rustgi AK, Schelley SL, Tejpar S, et al. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 2004; 363: 852–9
   PubMed Web of Science ®Google Scholar
• Cole SG, Begbie ME, Wallace GM, Shovlin CL. A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5. J Med Genet 2005; 42: 577–82
   PubMed Web of Science ®Google Scholar
• Bayrak-Toydemir P, McDonald J, Akarsu N, Toydemir RM, Calderon F, Tuncali T, et al. A fourth locus for hereditary hemorrhagic telangiectasia maps to chromosome 7. Am J Med Genet A 2006; 140: 2155–62
   PubMed Web of Science ®Google Scholar
• Brusgaard K, Kjeldsen AD, Poulsen L, Moss H, Vase P, Rasmussen K, et al. Mutations in endoglin and in activin receptor-like kinase 1 among Danish patients with hereditary haemorrhagic telangiectasia. Clin Genet 2004; 66: 556–61
   PubMed Web of Science ®Google Scholar
• Wehner LE, Folz BJ, Argyriou L, Twelkemeyer S, Teske U, Geisthoff UW, et al. Mutation analysis in hereditary haemorrhagic telangiectasia in Germany reveals 11 novel ENG and 12 novel ACVRL1/ALK1 mutations. Clin Genet 2006; 69: 239–45
   PubMed Web of Science ®Google Scholar
• Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 2000; 91: 66–7
   PubMed Web of Science ®Google Scholar
• Sankelo M, Flanagan JA, Machado R, Harrison R, Rudarakanchana N, Morrell N, et al. BMPR2 mutations have short lifetime expectancy in primary pulmonary hypertension. Hum Mutat 2005; 26: 119–24
   PubMed Web of Science ®Google Scholar